Kite, a Gilead Sciences company, recently reported new analysis showing that its CAR T therapy Yescarta delivers consistent ...

Gilead Sciences stock has seen its fair value estimate edge down only slightly, from about $130.83 to $130.63, even as the discount rate nudged up from roughly 7.26% to 7.29% and long term revenue ...

An updated Canadian guideline on HIV prevention addresses the expanding range of medications available to reduce the risk of ...

If injectable medication to prevent infection, which has gained favour across Canada, were widely available in B.C., it would ...

By shutting South Africa out of its overseas funding for the roll-out of the revolutionary six-monthly HIV prevention jab which could potentially end Aids, the Trump administration undercuts its own ...

Carlton V. Bell II won second place in GLAAD + STARZ TV Pilot Pitch Competition with a series that will destigmatize HIV.

By the way, GSK, realizing its potential in the MSI-H/dMMR market, is actively developing it for the treatment of colon ...

ACCRA/GENEVA, 10 December 2025 —African leaders can put the continent back on track to end AIDS by 2030 by choosing to ...

Gilead Foundation announced a commitment of more than $3 million in new grants to help address critical gaps in education, care delivery and support services for people affected by metastatic breast ...

South Africa, Eswatini and Zambia in December began administering a groundbreaking HIV-prevention injection in the drug's ...

Malawi Greenlights Injectable HIV Prevention Drug. Malawi has become the fourth African country to greenlight lenacapavir, a ...